2021
DOI: 10.1111/ejn.15110
|View full text |Cite
|
Sign up to set email alerts
|

Endocannabinoids and cortical plasticity: CB1R as a possible regulator of the excitation/inhibition balance in health and disease

Abstract: The endocannabinoid system has been linked to neurological disorders in which the excitation inhibition (E/I) balance of the neocortex is dysregulated, such as schizophrenia. The main endocannabinoid receptor type 1 of the central nervous system -CB1R -is expressed on different cell types, that when activated, modulate the cortical E/I balance. Here we review how CB1R signalling contributes to phases of heightened plasticity of the neocortex. We review the major role of the CB1R in cortical plasticity througho… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0

Year Published

2021
2021
2025
2025

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(14 citation statements)
references
References 167 publications
(202 reference statements)
0
11
0
Order By: Relevance
“…The elective activation of glutamate neurons in the primary CTX-M was related to the functional prognosis of patients and can promote functional recovery after SCI [44]. Other regulated genes not directly related to the NMDA net includes Cnr1 (Cannabinoid Receptor 1), which is involved in sensory deprivation-induced cortical plasticity by mediating long-term potentiation and depression of synapse strength and the fine-tune of excitatory/inhibitory balance [45]. Several growth factor-and growth factor receptor encoding genes are down-regulated, e.g., Igf1, Ntf3, Ntrk2.…”
Section: Discussionmentioning
confidence: 99%
“…The elective activation of glutamate neurons in the primary CTX-M was related to the functional prognosis of patients and can promote functional recovery after SCI [44]. Other regulated genes not directly related to the NMDA net includes Cnr1 (Cannabinoid Receptor 1), which is involved in sensory deprivation-induced cortical plasticity by mediating long-term potentiation and depression of synapse strength and the fine-tune of excitatory/inhibitory balance [45]. Several growth factor-and growth factor receptor encoding genes are down-regulated, e.g., Igf1, Ntf3, Ntrk2.…”
Section: Discussionmentioning
confidence: 99%
“…To test this hypothesis, we next investigated the possibility of reducing the spontaneous neuronal activity to rescue behaviorally-induced plasticity. The endocannabinoid system is a major neuromodulatory system with anti-inflammatory properties and neuroprotective effects both in vitro and in vivo 34,35 and is widely described in the somatosensory cortex [36][37][38][39] . Furthermore, endocannabinoids are released on-demand in an activity-dependent fashion 25 and can set the level of activity of neuronal networks 21 .…”
Section: Endocannabinoid-mediated Mitigation Of the Long-term Effects...mentioning
confidence: 99%
“…At the central nervous system (CNS) CB1R are especially abundant in the cortex, basal ganglia, hippocampus, and cerebellum ( Mackie, 2005 ). The great majority of CB1R can be found on axon terminals and pre-terminal axon segments, while sparing the active zone ( Nyiri et al, 2005 ) and play a well-established role in CNS function and dysfunction ( Durieux et al, 2022 ). By contrast, CB2R were found to play a central role in the immune system ( Leleu-Chavain et al, 2013 ), while in the CNS, CB2R are predominantly expressed in microglia and only a few years ago were they identified on neurons, at the postsynaptic somatodendritic region, in discrete areas of the brain ( Van Sickle et al, 2005 ; Onaivi et al, 2008 ).…”
Section: The Endocannabinoid Systemmentioning
confidence: 99%